426PA phase I trial of afatinib (Afa) and bevacizumab (Bev)...

Annals of Oncology 2017 / 11 Vol. 28; Iss. suppl_10

426PA phase I trial of afatinib (Afa) and bevacizumab (Bev) in chemo-naïve patients (pts) with advanced non-small-cell lung cancer (NSCLC) harboring EGFR-mutations: OLCSG1404

Harada, D, Nogami, N, Kozuki, T, Ninomiya, T, Bessho, A, Kuyama, S, Fujimoto, N, Sugimoto, K, Aoe, K, Ochi, N, Minami, D, Fukamatsu, N, Kudo, K, Kiura, K
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx671.015
Date:
November, 2017
File:
PDF, 61 KB
english, 2017
Conversion to is in progress
Conversion to is failed